HomeMarketsSharesTCG BDC, Inc.

Trade TCG BDC, Inc. - CGBD CFD

Market is not available at the momentMarket information is presented
as of 2026-10-05T19:46:56+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.05
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.022207 %
(-$4.44)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02221%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.000015 %
(-$0.00)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.00002%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close10.64
Open10.78
1-Year Change-13.34%
Day's Range10.54 - 10.78

Trade TCG BDC, Inc. - CGBD

About TCG BDC Inc

TCG BDC, Inc. is an externally managed, non-diversified closed-end investment company. The Company’s investment objective is to generate current income and capital appreciation primarily through debt investments. The Company's core investment strategy focuses on lending to the United States and middle-market companies. The Company seeks to achieve its investment objective primarily through direct origination of secured debt instruments. The Company’s first lien senior secured loans, including stand-alone first lien loans, first lien/last out loans and unitranche loans. Its Second lien senior secured loans, including Middle market senior loans with the balance of its assets invested in higher-yielding investments, including unsecured debt, mezzanine debt and investments in equities. The Company is managed by its investment adviser, Carlyle Global Credit Investment Management L.L.C.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, TCG BDC Inc revenues decreased 6% to $171.2M. Net income applicable to common stockholders increased from $4.6M to $156.9M. Revenues reflect Interest income from non-controlled/non- decrease of 8% to $134.4M, Other income from non-controlled/non-aff decrease of 42% to $6.4M, Interest income from controlled/affiliat decrease of 95% to $185K.

Latest shares articles

BNP Paribas stock forecast
BNP Paribas stock forecast: Q2 earnings beat estimates
BNP Paribas is a French banking group whose recent developments include a Swift ledger transaction with HSBC for Siemens and continued focus on eurozone interest rates. Explore third-party BNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
13 hours ago
Boeing stock forecast
Boeing stock forecast: FAA investigates Miami freighter crash
Boeing is a US aerospace manufacturer whose shares remain in focus after a 767-300 freighter crash in Miami prompted an FAA investigation. Explore third-party BA price targets and technical analysis. Past performance is not a reliable indicator of future results.
14 hours ago
CaixaBank stock forecast
CaixaBank stock forecast: BPI exits Angola market
CaixaBank is a Spanish bank whose Portuguese unit, Banco BPI, agreed to sell its 33.35% stake in Banco de Fomento de Angola for €388.5m. Explore third-party CABK price targets and technical analysis. Past performance is not a reliable indicator of future results.
15 hours ago
Valneva stock forecast
Valneva stock forecast: EMA validates Lyme vaccine application
Valneva is a French vaccine company listed on Euronext Paris. In August, the EMA validated the marketing-authorisation application for its Lyme disease vaccine candidate with Pfizer. Explore third-party VLA price targets. Past performance is not a reliable indicator of future results.
18 hours ago

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready